Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 hours agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
Novavax Stock (NASDAQ:NVAX): Too Much Bad News Can Fuel a Reversal
TipRanks via Yahoo Finance· 5 months agoBy most measures, investors have reason to be skeptical about vaccine specialist Novavax...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 1 month agoShares of the struggling vaccine developer Novavax (NASDAQ: NVAX) bounded 98.7% higher on Friday,...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 1 month agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
Could Novavax Stock Help You Become a Millionaire?
Motley Fool via Yahoo Finance· 5 months agoNovavax (NASDAQ: NVAX) stock may have made some millionaires back in 2020. It was the height of the coronavirus vaccine race, and investors were betting...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 1 month agoNovavax (NASDAQ: NVAX) has been a highly volatile stock in recent years, and that volatility is on full display again this month. Shares of the...
Could This Bullish News Make Novavax a Hot Buy?
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) is a beaten-down COVID stock that has seen its shares plummet 85% since the start of the year. For people who prefer a more...
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 5 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 1 week agoNovavax (NASDAQ: NVAX) stock is suddenly a buy again this year, with its stock price more than tripling since the start of 2024. Some positive...
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 1 month agoShares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker's first-quarter results. It's not the report,...
